Urothelial carcinoma is the 10th most common cancer globally with an almost 4 times higher prevalence in men. It is more prevalent in elderly population with 80% of the cases getting diagnosed in people above 65 years of age.1-3. Histologically, almost 90% of all bladder cancer cases in the United States and Europe are urothelial in origin. However, in other parts of the world, incidence of non-urothelial forms of bladder cancer have been reported to have increased, chiefly due to endemic schistosomiasis4.